Snowball logo
logo
MEHC

MEHCQ

MEHCQ • PINK
$3.50$0.00  (0%)
Estimate
EPS
-7.76
Beta
2.161
About the company
Ticker
MEHCQ
ISIN
Country
United States of America
Sector (GICS)
Other
23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally. The company provides personal genome service (PGS) that consists of a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. It also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; offers non-controlled medications for treatment of acute and chronic conditions; and provides Ozempic and Wegovy through its weight loss program, offering consumers with access to affordable weight management care. In addition, the company provides research services. 23andMe Holding Co. was founded in 2006 and is headquartered in San Francisco, California.

Frequently asked questions

What sector does MEHCQ (MEHCQ) operate in?

MEHCQ belongs to the Other sector and operates in the Diagnostics & Research industry.

What is MEHCQ (MEHCQ) current stock price?

As of the latest data, MEHCQ stock price is $3.50, with a previous close of $3.50.

What is MEHCQ (MEHCQ) current market capitalization?

MEHCQ market cap is approximately 89.01 million.

What is MEHCQ (MEHCQ) Earnings Per Share (EPS)?

The trailing EPS is -$7.76.

Does MEHCQ (MEHCQ) pay dividends?

No. MEHCQ does not pay a dividend.

What is MEHCQ (MEHCQ) beta (volatility) score?

MEHCQ has a beta of 2.161, indicating very high volatility compared to the market.